SLNO – soleno therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC
Indo US Bridging RARE Summit Highlights Patient Stories, Affordable Innovation, and Calls for Global Collaborations
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $74.00 price target on the stock.
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "outperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $72.00 price target on the stock.
Form 4 SOLENO THERAPEUTICS INC For: Jan 02 Filed by: Mackaness James H
Form 4 SOLENO THERAPEUTICS INC For: Jan 02 Filed by: Yen Kristen
Form 4 SOLENO THERAPEUTICS INC For: Jan 02 Filed by: Hirano Patricia C
Form 4 SOLENO THERAPEUTICS INC For: Jan 02 Filed by: Anish Bhatnagar
Form 8-K SOLENO THERAPEUTICS INC For: Dec 17
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.